---
title: Myasthenia gravis
author: Harvey Guo
created: <% tp.file.creation_date() %>
modified: <% tp.file.last_modified_date() %>
aliases: []
share: true
---

Associated with [[Thymoma]].
# Pathophysiology
## [Thymus](https://next.amboss.com/us/article/960NMS#Z2280a528c47a8e93bb70fb96d798d351) involvement
<mark style="background: #FFF3A34A;">Muscle-like (myoid) cells in the [thymus](https://next.amboss.com/us/article/960NMS#Z2280a528c47a8e93bb70fb96d798d351) express AChR → autoreactive targeting by [T cells](https://next.amboss.com/us/article/x50Emg#Zb648e3ccdd39ac912f7d40f71b5d94c0) → production of [acetylcholine receptor antibodies](https://next.amboss.com/us/article/DR016f#Z642e66e911b1990368ae56b2e38c6893) ([AChR antibodies](https://next.amboss.com/us/article/DR016f#Z642e66e911b1990368ae56b2e38c6893))</mark>
## Acetylcholine receptor antibodies [4]
- Responsible for inhibition of [signal transduction](https://next.amboss.com/us/article/qo0C1S#Z120b3d64e4c26c0c457ea26dcc34727c) at the [neuromuscular junction](https://next.amboss.com/us/article/lp0vpS#Z3c15ed824470b5b7ec72fc4c39ee3075) (NMJ)
- [Antibodies](https://next.amboss.com/us/article/x50Emg#Zcafc1c81671c54115ab5d77c08d696a0) target postsynaptic AChRs of normal muscle cells → competitive inhibition of [acetylcholine](https://next.amboss.com/us/article/lp0vpS#Z3c3ab1c3772cabdb26be3c413ba52df4) ([ACh](https://next.amboss.com/us/article/lp0vpS#Z3c3ab1c3772cabdb26be3c413ba52df4)) → AChR decay through [receptor](https://next.amboss.com/us/article/qo0C1S#Z3ff0122a3c004eebed96e9db47e16ea4) internalization (↓ [receptor](https://next.amboss.com/us/article/qo0C1S#Z3ff0122a3c004eebed96e9db47e16ea4) density at the postsynaptic membrane) and activation of complement (→ muscle cell lysis) → impaired [signal transduction](https://next.amboss.com/us/article/qo0C1S#Z120b3d64e4c26c0c457ea26dcc34727c) at the NMJ → [skeletal muscle](https://next.amboss.com/us/article/so0tWS#Z6f7ea6c70fce86b21d8ffeb1772bdfe0) weakness and fatigue 
    - Seropositive MG (80–90% of cases): positive assays for [antibodies](https://next.amboss.com/us/article/x50Emg#Zcafc1c81671c54115ab5d77c08d696a0) (in blood) against the acetylcholine receptor ([AChR-Ab](https://next.amboss.com/us/article/DR016f#Z642e66e911b1990368ae56b2e38c6893))
    - Seronegative MG (10–20% of cases): negative for [AChR antibodies](https://next.amboss.com/us/article/DR016f#Z642e66e911b1990368ae56b2e38c6893), but may be positive for muscle-specific tyrosine kinase antibodies (MuSK antibodies)
	![[Pasted image 20230622145302.png]]
# Comparison of Myasthenia gravis and Lambert-Eaton myasthenic syndrome (LEMS)
![[Pasted image 20230921164528.png]]
>[!tip] 
> 1. Extraocular muscles: move frequently, so they are first affected.
> 2. MG: Repeated nerve stimulation → ↓ ACh release → improved symptoms
> 3. LEMS: More depolarization → more ACh release → improved symptoms